Ridgetech, Inc. income statement RDGT
In fiscal 2026, which ended Mar 31, 2026, Ridgetech, Inc. reported revenue of $132.2 million, up 10.2% from the year before. It recorded a net loss of $1.3 million. The operating loss came to $1.9 million, an operating margin of -1.4%. Diluted earnings per share were -$17.21. Across the 5 fiscal years shown, revenue shrank from $164.4 million in fiscal 2022 to $132.2 million in fiscal 2026, about 5.3% a year.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2026
Mar 31, 2026
|
FY 2025
Mar 31, 2025
|
FY 2024
Mar 31, 2024
|
FY 2023
Mar 31, 2023
|
FY 2022
Mar 31, 2022
|
|---|---|---|---|---|---|
| Revenue |
132
+10.2%
|
120
-3.2%
|
124
+3.2%
|
120
-26.9%
|
164
|
| Cost of revenue |
127
+9.7%
|
116
-2.5%
|
119
+2.2%
|
117
-8.8%
|
128
|
| Gross profit |
5
+23.8%
|
4
-21.3%
|
5
+35.5%
|
4
-90.1%
|
37
|
| Selling, general and administrative |
7
+35.8%
|
5
+13.8%
|
4
-33.1%
|
6
-83.6%
|
39
|
| Operating expenses |
7
+35.8%
|
5
+13.8%
|
4
|
—
|
—
|
| Operating income |
-2
-80.2%
|
-1
-273.7%
|
1
+104.5%
|
-13
-388.6%
|
-3
|
| Other income (expense) |
1
|
—
|
—
|
—
|
—
|
| Pretax income |
-1
-42.0%
|
-1
-14.9%
|
-1
+94.6%
|
-15
-635.8%
|
-2
|
| Income tax |
-0
-119.7%
|
1
+1317.3%
|
-0
-110.5%
|
0
-64.1%
|
1
|
| Net income |
-1
-112.3%
|
10
+340.8%
|
-4
+80.0%
|
-21
-562.2%
|
-3
|
| Basic EPS |
-17.21
-106.2%
|
275.87
+162.7%
|
-439.78
-960.7%
|
-41.46
-125.9%
|
-18.35
|
| Diluted EPS |
-17.21
-106.2%
|
275.87
+162.7%
|
-439.78
-960.7%
|
-41.46
-125.9%
|
-18.35
|
| Weighted average shares, basic |
0
+96.6%
|
0
+283.8%
|
0
-98.1%
|
1
+193.1%
|
0
|
| Weighted average shares, diluted |
0
+96.6%
|
0
+283.8%
|
0
-98.1%
|
1
+193.1%
|
0
|
| Other measures | |||||
| Depreciation and amortization |
0
-68.0%
|
1
+43.9%
|
1
+10.1%
|
1
-42.9%
|
1
|
| EBITDA |
-2
-1574.3%
|
0
-92.7%
|
1
+111.1%
|
-12
-765.8%
|
-1
|
| Interest coverage |
-27.82x
|
—
|
—
|
—
|
—
|
| Margins | |||||
| Gross margin |
3.60%
|
3.20%
|
3.93%
|
3.00%
|
22.21%
|
| Operating margin |
-1.41%
|
-0.86%
|
0.48%
|
-10.95%
|
-1.64%
|
| Pretax margin |
-1.02%
|
-0.79%
|
-0.67%
|
-12.85%
|
-1.28%
|
| Profit margin |
-0.95%
|
8.50%
|
-3.41%
|
-17.59%
|
-1.94%
|
| EBITDA margin |
-1.14%
|
0.08%
|
1.12%
|
-10.35%
|
-0.87%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Retail-Drug Stores and Proprietary Stores (SIC 5912)
- Listed as
- RDGT (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Cayman Islands
- Headquarters
- Hangzhou City, China
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1856084
- Former names
- China Jo-Jo Drugstores, Inc. (until Feb 5, 2025); China Jo-Jo Drugstores Holdings, Inc. (until Jun 16, 2023)
Other Retail-Drug Stores and Proprietary Stores companies
- CVS HEALTH Corp CVS
- Guardian Pharmacy Services, Inc. GRDN
- 111, Inc. YI
- Petmed Express Inc PETS
- TREES Corp (Colorado) CANN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.